Vibrating sleeve shows promise for swollen arms
NCT ID NCT06407791
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new vibrating device called LymphaVibe for treating arm lymphedema, a painful swelling from fluid buildup. Fifteen adults with lymphedema used the device for 40 minutes during a clinic visit. Researchers measured arm size, pain, and side effects before and after use, and compared results to standard care. The goal was to see if the device is safe and can reduce swelling.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- LymphaVibe device (vibratory therapy)
- What this could lead to
- If it works, this could offer a new, non-invasive way to reduce arm swelling and discomfort from lymphedema.
- What could go wrong
- This is a very small, early study with only 15 people and no comparison group. The device may not prove effective or safe in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
15 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years of age or older * Clinical diagnosis of lymphedema * Receiving current, once weekly, lymphedema treatment by Physical Therapist(PT)/Occupational Therapist (OT) * Participants must have the ability to provide consent for themselves Exclusion Criteria: * Active infection * Active cancer (not in remission) * Diagnosis of/past medical history of Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE) * Active phlebitis * Diagnosis of Congestive Heart Failure (CHF) * Previous severe trauma (i.e. requiring extensive corrective surgery) * History of vascular surgery * Lesions of the skin or weeping in the treatment area
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lymphedema are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Carilion Clinic
Roanoke, Virginia, 24014, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could gut bacteria predict infection risk in lymphedema?
- Could simple arm exercises improve life after breast cancer?
- Could online therapy ease the swelling of breast cancer lymphedema?
- Ultrasound could uncover hidden vascular risks in turner syndrome
- Can swollen limbs throw off your balance? a study investigates
- Could reapplying compression bandages three times a day beat the standard Once-Daily treatment for lymphedema?